Exclusive

Publication

Byline

Location

Clinical Trial: A Study on Treatment Preferences Regarding Dosage Forms of Dementia Medications in Japan (Japan)

Tokyo, April 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061264) titled 'A Study on Treatment Preferences Regarding Dosage Forms of Dementia Medica... Read More


Clinical Trial: Effects of very slow frequency transcranial alternating current stimulation on swallowing function and swallowing-related brain activity (Japan)

Tokyo, April 16 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061252) titled 'Effects of very slow frequency transcranial alternating current stimulatio... Read More


Clinical Trial: Effects of Device Type and Operator Experience on Nasotracheal Intubation Time (Japan)

Tokyo, April 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061281) titled 'Effects of Device Type and Operator Experience on Nasotracheal Intubation ... Read More


Clinical Trial: The Effect of Using a Vegetable Intake Survey on Vegetable Intake and Obesity Levels of Children Attending Pediatric Clinics for Obesity Treatment (Japan)

Tokyo, April 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061279) titled 'Effects on vegetable intake and obesity levels in children attending pedia... Read More


Clinical Trial: Effects of Small-Group Recreation for Older Adults with Moderate to Severe Dementia: An analysis of social proximity and interaction in daily life (Japan)

Tokyo, April 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061278) titled 'How does small-group recreation affect social interaction in daily life fo... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 15 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More